| TheraFuse is an emerging technology company engaged in design and development of advanced non-contact optical flow sensors for industrial, commercial and medical applications where accuracy and precision are paramount. |
||
driven by the onset of ever-shrinking MEMS-enabled devices focused on market sectors such as bio-technology, electro-chemistry and micro-fluidics. Core Technology
time-of-flight can be used to measure fluid flow rate over the range of drug infusion rates required for most therapeutic settings, from the very low infusion rates for basal insulin in neonates to the very high infusion rates required for IV drug delivery in a hospital setting. TheraFuse has designed completely stand-alone prototypes to further demonstrate the robustness of the technology in non-laboratory settings. The performance of these prototypes has been measured in AAMI-compliant accuracy and precision studies and in animal studies. For further information about our technology and its application in precision drug delivery, please Contact Us. Partnerships
has responded to market requests by offering special expertise to clients worldwide. We have executed research and development activities in the areas of infusion monitoring and metering, ambulatory drug delivery, and general precision flow monitoring. We are currently partnering with OEM's looking for new ways to increase the accuracy and portability of drug delivery devices. Please Contact Us directly to discuss YOUR application. |
||